Search Results - "Pais, Raluca"

Refine Results
  1. 1

    Relationship Among Fatty Liver, Specific and Multiple‐Site Atherosclerosis, and 10‐Year Framingham Score by Pais, Raluca, Redheuil, Alban, Cluzel, Philippe, Ratziu, Vlad, Giral, Philippe

    Published in Hepatology (Baltimore, Md.) (01-04-2019)
    “…Despite a well‐documented increase in the prevalence of subclinical atherosclerosis in patients with steatosis, the relationship among steatosis and…”
    Get full text
    Journal Article
  2. 2

    From NAFLD in clinical practice to answers from guidelines by Nascimbeni, Fabio, Pais, Raluca, Bellentani, Stefano, Day, Christopher Paul, Ratziu, Vlad, Loria, Paola, Lonardo, Amedeo

    Published in Journal of hepatology (01-10-2013)
    “…Summary This review of the literature consists of three sections. First, papers concerning non-alcoholic fatty liver disease (NAFLD) awareness among the…”
    Get full text
    Journal Article
  3. 3

    Natural History of NAFLD by Pais, Raluca, Maurel, Thomas

    Published in Journal of clinical medicine (10-03-2021)
    “…The epidemiology and the current burden of chronic liver disease are changing globally, with non-alcoholic fatty liver disease (NAFLD) becoming the most…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Metabolic syndrome and risk of subsequent colorectal cancer by Pais, Raluca, Silaghi, Horatiu, Silaghi, Alina-Cristina, Rusu, Mihai-Lucian, Dumitrascu, Dan-Lucian

    Published in World journal of gastroenterology : WJG (07-11-2009)
    “…The metabolic syndrome and visceral obesity have an increasing prevalence and incidence in the general population. The actual prevalence of the metabolic…”
    Get full text
    Journal Article
  6. 6

    Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease by Zambon Azevedo, Vittoria, Silaghi, Cristina Alina, Maurel, Thomas, Silaghi, Horatiu, Ratziu, Vlad, Pais, Raluca

    Published in Frontiers in nutrition (Lausanne) (17-01-2022)
    “…An extensive body of the literature shows a strong interrelationship between the pathogenic pathways of non-alcoholic fatty liver disease (NAFLD) and…”
    Get full text
    Journal Article
  7. 7

    Metabolic Dysfunction Associated Liver Disease in Patients Undergoing Coronary Computed Tomography Angiography by Orzan, Rares Ilie, Gligor, Rares Ioan, Agoston, Renata, Cionca, Carmen, Zlibut, Alexandru, Pais, Raluca, Seicean, Andrada, Agoston-Coldea, Lucia

    “…In this single-center cross-sectional study on patients undergoing coronary computed tomography angiography (CCTA), we assessed the prognostic significance of…”
    Get full text
    Journal Article
  8. 8

    The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis B and Drug-Induced Liver Disease by Pais, Raluca, MD, PhD, Rusu, Elena, MD, PhD, Ratziu, Vlad, MD, PhD

    Published in Clinics in liver disease (01-02-2014)
    “…Steatosis and insulin resistance (IR) are no more frequent in chronic hepatitis B (CHB) than in the general population. Although experimental studies suggest…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Editorial: statin use in patients with NAFLD—safety concerns, decreased awareness or both? by Mallet, Maxime, Pais, Raluca

    “…LINKED CONTENT This article is linked to Henson et al papers. To view these articles, visit https://doi.org/10.1111/apt.16646…”
    Get full text
    Journal Article
  11. 11

    Editorial: it is not a wide‐open field for incretins ‐ collateral benefits favour the use of metformin in advanced non‐alcoholic steatohepatitis by Ratziu, Vlad, Pais, Raluca

    Published in Alimentary pharmacology & therapeutics (01-09-2019)
    “…LINKED CONTENT This article is linked to Vilar‐Gomez paper. To view this article, visit https://doi.org/10.1111/apt.15331…”
    Get full text
    Journal Article
  12. 12

    Fatty liver and renal function impairment – Time for awareness? by Pais, Raluca, Bourron, Olivier

    Published in Journal of hepatology (01-01-2018)
    “…Because of the pathogenic cross-talk between the liver and inflamed adipose tissue it is now widely accepted that non-alcoholic fatty liver disease (NAFLD) is…”
    Get full text
    Journal Article
  13. 13

    A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver by Pais, Raluca, Charlotte, Fréderic, Fedchuk, Larissa, Bedossa, Pierre, Lebray, Pascal, Poynard, Thierry, Ratziu, Vlad

    Published in Journal of hepatology (01-09-2013)
    “…Background & Aims Disease progression in non-alcoholic fatty liver disease (NAFLD) is not well understood and there is controversy about whether non-alcoholic…”
    Get full text
    Journal Article
  14. 14

    Accuracy of quantitative ultrasound parameters in the diagnosis of osteoporosis by Pais, Raluca, Campean, Remus, Simon, Siao-Pin, Bolosiu, Calin R., Muntean, Laura, Bolosiu, Horatiu D.

    Published in Central European journal of medicine (01-08-2010)
    “…Quantitative ultrasound (QUS) is of increasing interest for evaluation of osteoporosis because, compared with dual-energy X-ray absorptiometry (DXA), it is…”
    Get full text
    Journal Article
  15. 15
  16. 16

    NAFLD and liver transplantation: Current burden and expected challenges by Pais, Raluca, Barritt, A. Sidney, Calmus, Yvon, Scatton, Olivier, Runge, Thomas, Lebray, Pascal, Poynard, Thierry, Ratziu, Vlad, Conti, Filomena

    Published in Journal of hepatology (01-12-2016)
    “…Summary Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing both in Europe…”
    Get full text
    Journal Article
  17. 17

    Epicardial adipose tissue and relationship with coronary artery disease by Silaghi, Alina Cristina, Pais, Raluca, Valea, Ana, Mironiuc, Aurel Ion, Silaghi, Horatiu

    Published in Central European journal of medicine (01-06-2011)
    “…Epicardial adipose tissue (EAT) is metabolically active tissue that accumulates around the coronary arteries. Epicardial fat is a rich source of free fatty…”
    Get full text
    Journal Article
  18. 18

    Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease by Nascimbeni, Fabio, Bedossa, Pierre, Fedchuk, Larysa, Pais, Raluca, Charlotte, Frédéric, Lebray, Pascal, Poynard, Thierry, Ratziu, Vlad

    Published in Journal of hepatology (01-05-2020)
    “…Histological classifications used to diagnose/stage non-alcoholic fatty liver disease (NAFLD) are based on morphology, with undetermined clinical correlates…”
    Get full text
    Journal Article
  19. 19

    Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study by Sultanik, Philippe, Lherault, Guillaume, Bouzbib, Charlotte, Ratziu, Vlad, Pais, Raluca, Mouri, Sarah, Thabut, Dominique, Rudler, Marika

    Published in Alimentary pharmacology & therapeutics (01-09-2024)
    “…Summary Background and Aims The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD)‐related cirrhosis has been increasing these last…”
    Get full text
    Journal Article
  20. 20